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Abstract 
Cell migration requires a precise temporal and spatial coordination of several processes which 
allow the cell to efficiently move. The extension and retraction of membrane protrusion, as well 
as adhesion are controlled by the Rho-family small GTPases. Two members of the family, Rac1 
and RhoA, can show opposite behaviours and spatial localisations, with RhoA being active 
toward the rear of the cell and regulating its retraction during migration, whereas Rac1 is active 
towards the front of the cell. In addition to the spatial segregation, RhoA and Rac1 activity at 
the leading edge of the cells has an element of temporal segregation, with RhoA and Rac1 
activities peaking at separate points during the migratory cycle of protrusion and retraction. 
Elements of this separation have been explained by the presence of two mutually inhibitory 
feedbacks, where Rac1 inhibits RhoA and RhoA in turn can inhibit Rac1. Recently, it was 
shown that Rac1 and RhoA activity and downstream signalling respond in a bistable manner to 
perturbations of this network. 
 
Main text 
The small GTPases of the Rho family have been established as crucial signalling effectors 
regulating cellular morphology and, consequently, locomotion 1. Activation of RhoA and Rac1, 
two members of the family, has been shown to induce the formation of membrane protrusions 
and retractions as well as the regulation of actin polymerisation into filaments.  
The activity of Rho-family GTPases is determined by their guanine nucleotide-bound state and 
their localisation. Upon binding of GTP, Rho-GTPases undergo a conformational change which 
exposes effector binding domains, consequently greatly increasing the affinity for downstream 
signal transducers. This induces the translocation of these proteins to the membrane resulting in 
their activation and triggering downstream signalling thorough cascades which ultimately lead 
to modulation of cellular functions. On the other hand, GDP-bound GTPases are inactive, as 
they are locked in a conformation where the effector binding domain is masked. 
The switching from GDP and GTP bound (or inactive to active) states is tightly controlled by a 
family of regulatory proteins that interact with GTPases and promote the exchange of GDP to 
GTP.  Guanine nucleotide exchange factors (GEFs) promote the dissociation of GDP from the 
GTPase, which then preferentially binds GTP, as it is available in excess over GDP in the cell. 
The inactivation of the GTPase is induced by the binding of GTPase activating proteins (GAPs). 
GAPs greatly increase the intrinsic hydrolysis activity of the GTPases, promoting the 
conversion of GTP to GDP 2. 
RhoA is predominantly active toward the rear of the cell where it induces the retraction of the 
lagging end of the cell through action-myosin contractility. A smaller pool of active RhoA is 
present at the leading edge of the cell. In contrast to the near constitutive activity at the rear, 
RhoA activity at the front of the cell is highly dynamic and is sometimes induced only for a few 
seconds 3. Intriguingly, RhoA activity at the leading edge precedes the formation of a membrane 
protrusion.  Rac1 on the other hand is nearly exclusively active at the very leading edge of 
migrating cells. Interestingly, the activities of both GTPases are clearly segregated, either 
spatially, with RhoA active at the rear and Rac1 at the front or indeed temporally with RhoA 
activity peaking before Rac1 at the leading edge of the cell during the protrusion-retraction 
cycle 4. This exclusivity has been explained by demonstrating that RhoA and Rac1 are 
embedded in a mutual inhibitory feedback loops.  Rac1 has been shown to reduce RhoA activity 
through multiple mechanisms, some of which are dependent on the downstream effector kinase 
PAK 5. PAK has been reported to phosphorylate and inactive several RhoA-specific GEFs. In 
particular, phosphorylation GEF-H1 by PAKs on a C-terminal serine residue has been shown to 
induce the association of 14-3-3 proteins which leads to the sequestration of GEF-H1 to the 
microtubules where it is inactive and unable to promote the exchange of RhoA-GDP to GTP 6. 
Conversely, RhoA-GTP has also been shown to decrease Rac1 activity through activation of the 
downstream effector kinases ROCK1/2. ROCK has been shown to supress Rac1-GTP by 
directly phosphorylating FilGAP 7. In addition, in melanoma cells, the ROCK-dependent 
suppression of Rac-activity requires ARHGAP22. The precise mechanism of how this is 
mediated is as yet unclear, but it appears to be indirect as no ROCK dependent phosphorylation 
of ARHGAP22 was detected 8. 
Such a reciprocally regulated network structure can give rise to several distinct behaviours , 
depending on parameters, such as protein concentrations and activities. Firstly, such systems 
will react in a switch-like manner in response to perturbations, with either RhoA or Rac1 
activities changing marginally until a tipping point is reached upon with a dramatic switching 
would occur. Depending on the wiring of the network this switch could be reversible, meaning 
that when the perturbation is removed the reversal switch would occur at the same position. 
Alternatively, such a reversal in activities could happen at distinct points, meaning that upon a 
perturbation Rac1 activity could be high or low depending on what the initial activity of Rac1 
was when the system was perturbed, a so called bistable system. In fact it could even occur that 
RhoA and Rac1 activities would be locked permanently at a new level after a perturbation, 
resulting in an irreversible switch. In several model systems, RhoA activity has been recently 
shown to be bimodally distributed, spatially separate, excitable and travelling in waves, all 
hallmarks of a potentially bistable system 9-12. 
In a recent paper, we went on to explore under which circumstances bistability of the system 
would emerge and to determine how this would affect the Rho-GTPases, downstream signalling 
and cellular behaviour 13. We combined kinetically detailed as well as coarse-grained 
mathematical models of the Rac1-RhoA interaction network focusing on the mutually inhibitory 
crosstalk between these GTPases mediated via p21-activated kinase (PAK). By employing 
mathematical models encompassing increasing levels of abstraction that retain the essential 
network features, we could flexibly zoom in and out of the network structure and conduct 
comprehensive, complementary computational analyses. In combination, these in silico analyses 
allowed us to untangle the network complexity and identify the key conditions that characterize 
the network input-output responses. Importantly, model predictions helped to formulate 
hypotheses and design appropriate experiments to test them. Using the highly motile MDA-
MB-231 breast cancer cell line as the experimental model, we predicted and validated the 
presence of bistability at various levels via manipulation of PAK using a small inhibitor, IPA-3. 
By gradually inhibiting PAK activity starting from control (active PAK, no IPA-3) cells, or re-
triggering PAK after pre-treating the cells with high doses of IPA-3, we could trace distinct 
input-output trajectories reflecting the hysteresis curves, a hallmark of bistable behaviours. We 
demonstrated bistability in the activities of Rac1 and RhoA, as well as bistable responses of 
actin dynamics, cell migration and the switching of cell morphology from elongated, 
mesenchymal to a rounded, amoeboid-like shape in 3-dimensional matrices. 
A significant advance of a model-led analysis framework is the ability to forecast answers to 
newly posed questions that have not been experimentally tested before, through model 
simulations. Although such predictions have to be ultimately validated by experiments they 
nevertheless offer valuable insights into the mechanism-behaviour relationship, and inform 
what can be expected which helps direct optimal experimental directions. Having validated the 
Rac1-PAK-RhoA model in MDA-MB-231 cells, we asked whether such bistable behaviour is a 
common feature in other cell types. To probe this question, we first extracted publicly available 
protein expression data of several key model components from a variety of cell types of 
different origins 14, 15. While the order of abundance of the extracted proteins is conserved 
across the cell lines, with 14-3-3 being the most and GEF-H1 the least abundant, the copy 
number of each protein tends to vary strongly (~1-2 orders of magnitude) between the cell lines 
(Fig. 1A). This raises the possibility that the existence of bistability observed in MDA-MB-231 
may be dependent on specific molecular contexts. 
Given a fixed network wiring, the dynamic behaviours of a network model are determined by 
the values of its kinetic parameters and state variables (e.g. expression of the network nodes). 
Because these parameters may vary between different cell types, the network can potentially 
display context-specific behaviours. It is reasonable to assume that kinetic parameters involved 
in protein-protein interactions or enzymatic reactions such as dissociation constants (Kds), 
catalytic constants (kcats) and Michaelis-Menten constants (Kms) are cell type independent, i.e. 
their values are conserved between different host cells. However, parameters including 
degradation or synthesis rates can vary between cell types, as these parameters often 
encapsulate and are therefore dependent on the regulatory enzymes (i.e. E3 ligases or 
transcriptional factors), whose levels may well differ between the cell types. Similarly, as 
models often lump multiple reactions for simplicity, parameters describing these reactions are 
dictated by the levels of the lumped nodes; and because these nodes may have different 
abundance between different cell types, the lumped parameters are likely cell type specific. 
Together, these argue that in addition to the commonly observed variation in the expression of 
network nodes, kinetic parameters can also be under strong variation across different cell types. 
Nevertheless, since our Rac1-RhoA model consists mainly of Kds, kcats and Kms, which are 
likely to be invariant across different cellular backgrounds, the model could be utilised to 
explore possible divergent network behaviours in different cell lines based on protein 
expression variations. 
To this end, when we populated the model with cell type-specific expression profiles, model 
simulations predicted that only some of the tested cell types display switch-like, ultrasensitive 
response behaviours and, surprisingly, none apart from MDA-MB-231 exhibited bistablity (Fig. 
1B). On one hand, this suggests we were rather lucky in choosing MDA-MB-231 as the model 
to investigate bistability, as the abundances of network components in this cell type seemed to 
be just “right” for bistability. On the other hand, as the model we have used is an abstraction of 
the complete network, it is quite possible that Rac1- RhoA behave bistable in some of these cell 
lines if the cross-talk between the two GTPases is not primarily mediated via PAK and GEF-
H1. Nevertheless, these simulations highlight the benefit of model-based analysis as they would 
have pointed us to MDA-MB-231 as the optimal model to expose bistable behaviours in 
response to PAK inhibition. These simulations also explain the often observed cell-to-cell 
heterogeity in responses to perturbations by targeted therapy, attributed to by the variations in 
expression profiles between different cell types.  
Irreversible switch based therapy 
Bistable switches are often thought of as two-way switches, where the output response can be 
switched “On” or “Off” depending on the direction of the input perturbation and history of the 
system. However, bistability can also manifest as one-way, irreversible switches where the 
output is locked permanently at a new level after a perturbation and cannot be turned back even 
by the reversal of that perturbation. As a result, the output is “trapped” in either the “On” or 
“Off” state irrespective of the perturbation status. This concept is particularly attractive in the 
context of targeted therapeutics as it suggests that once an inhibitor exceeds a threshold to 
suppress an oncogenic signal, even a complete withdrawal of that inhibitor would not re-trigger 
the inhibited signal, thereby minimizing harmful side-effects due to off-target specificity of the 
drug. Interestingly, although our model did not predict the existence of irreversible switch at the 
measured levels of the network nodes in MDA-MB-231 cells, it predicts presence of this type of 
switch at a lower intracellular Rac1 abundance (Fig. 1C). In this case, increasing the dose of the 
PAK inhibitor IPA-3 would permarnently lock RhoA and Rac1 activities in an active and 
inactive state, respectively, without having to replenish the inhibitor in cells, and subseqeuently 
promote an amoeboid switch (Fig. 1D, blue line). Our simulations however indicate that the 
existence of this irreversible switch may only occur in a small sub-population of cells as it was 
strongly parameter dependent and predicted to occur over a narrow range of Rac1 expression. If 
Rac1 is lower than this range, the system exhibits only simple monostable response (Fig. 1D, 
black line), while if Rac1’s level exceeds this range, the systems displays robust reversible 
bistable responses (red line).  
While this is the case in MDA-MB-231 cells, given the observed cell-type specific variations in 
protein expressions it is reasonable to expect that the conditions for irreversible switch may well 
be less stringent in other cells. A potentially interesting scenario is the presence of an 
irreversible switch in tumour cells but its absence in normal cells, possibly due to difference in 
network nodes’ expression profiles, in which case withdrawing the drugs does not affect its 
efficacy in cancer cells but reverse its effect in normal cells, thereby minimizing deleterious 
side-effects. It is not clear how such scenario is likely to occur but it is almost of certainty that 
mathematical modelling and computational analysis will be again instrumental in guiding 
necessary perturbations to induce the network into exhibiting irreversible switches, which can 
be then exploited for targeted therapies. 
Subcellular segregation of network components renders site-specific dynamics 
Our mathematical model was purposely constructed to capture the whole-cell effects of the 
Rac1-RhoA interaction network, however mounting evidence suggest that there is 
spatiotemporal segregation of the network components between different subcellular 
localisations, which are highly dynamic and context-dependent 4, 16. For example, RhoA is often 
observed to be active at the rear of a polarised cell, while it can be low or high at different 
patches at the cell front. Similarly, the level of Rac1-GTP tends to be low at the cell rear but 
could be low or high at the cell’s leading edge, where it seems to lock in a localised mutual 
antagonistic relationship with RhoA. Additionally, FilGAP, a major GAP for Rac1, localises 
with F-actin and filamin A (FLNA) at the cell rear and in patches of actin bundles at membrane 
ruffles 17. FilGAP is also localised at some protrusion and adhesion points, exactly where high 
RhoA activity is expected 17. These data suggests distinct profiles of the network nodes at the 
front and back of a migrating cell, characterised either by a combination of low Rac1, high 
RhoA, high FilGAP or high Rac1, low RhoA, low FilGAP.  
 
To interrogate the local behaviour of the Rac1-RhoA network dynamics at different sites in 
migrating cells the models need to be spatially-resolved, to capture site-specific expression and 
activity profiles and account for possible variations in network topology that can be rewired 
across the sites. These models can be used to probe a range of exciting questions: How does 
bistability change between different subcellular localisations? Would there be the more intricate 
dynamics, such as oscillation and excitability, and how do they interplay?  Can information be 
fed back and forth between components of neighbouring sites and if so, how would the site-
specific dynamics be influenced? Clearly, the development of these models will be attractive 
avenues for future research. Initially, one can however attempt to gain understanding into site-
specific dynamics of the Rac-RhoA interactions by utilising our whole-cell model. As an 
illustration, we populated our model with different profiles of Rac1/RhoA/FilGAP. Model 
simulations show that upregulation of Rac1 combined with downregulation of RhoA and 
FilGAP drive the system away from bistability towards more linear, monostable responses (Fig. 
2A, B). As a result, the Rac1/RhoA responses to PAK inhibition could be different depending 
on the locations as demonstrated in Fig. 2C. Fortunately, next-generation GTPase activity 
probes, which allow quantifying Rho-GTPase activities at the sub-cellular level robustly, have 
been created which will prove invaluable to validate these predictions 18. Using these tools it 
was recently shown that CDC42 and RhoA activities are also spatially and temporally 
segregated during neutrophil chemotaxis 9. RhoA activity was shown to be bimodally 
distributed indicating that in this system bistability is also likely. 
 
 
Disclosure of potential conflicts of interest 
No potential conflicts of interest were disclosed. 
Acknowledgement 
AK and LKN acknowledge support from Breast Cancer NOW award 2013NovPR183, BNK 
support from the FP7 SynSignal (Grant agreement number 613879) and H2020 SmartNanoTox 
(Grant agreement number 686098). 
Figure legends 
Figure 1. Model simulations of network dynamics under different conditions. (A) Cell-
specific abundances of key network components in different cell-types determined by Mass 
Spectrometry (analysed from 14). (B) Simulated responses to increasing Rac1 inhibitor (IPA-3), 
plotted for RhoA-GTP as an example, for different cell types. The inbox shows the response for 
the remaining cells which display non-sigmoidal behaviours. (C) Graphical illustration of 
targeted therapeutic strategy that utilises an irreversible switch. (D) Simulations showing the 
sensitivity of the bistable switch to the concentration of Rac1. All model simulations were 
performed using our model published in 13. The concentration units for RhoA-GTP are in μM. 
Figure 2. Subcellular site-specific simulations of network behaviours. (A,B) Simulated 
responses to increasing PAK inhibitor (IPA-3) for active Rac1 and RhoA as the concentrations 
of Rac1, RhoA and Rac1’s GAP are simultaneously altered. (C) Illustrative simulations of the 
network responses at specific subcellular sites characterised by different expression profiles of 
the network nodes. All model simulations were performed using our model published in 13. The 
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